GLIOBLASTOMA (GBM)
Clinical trials for GLIOBLASTOMA (GBM) explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA (GBM) trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA (GBM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gene therapy aims to turn the body against deadly brain cancer
Disease control Not yet recruitingThis study is testing a new gene therapy called TGX-007 for people with a fast-growing type of brain cancer called glioblastoma. The therapy uses a harmless virus to deliver two treatments directly into the tumor: one to kill cancer cells and another to activate the patient's own…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: PHASE1, PHASE2 • Sponsor: Trogenix ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Early trial tests targeted drug for deadly brain tumor
Disease control Not yet recruitingThis study is testing a new drug called BGB-58067 for adults newly diagnosed with a fast-growing brain cancer called glioblastoma (GBM). The main goals are to see if the drug reaches the brain tumor effectively and if it is safe. The study will also check if the drug helps patien…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New weapon tested against deadly brain cancers that Won't quit
Disease control Not yet recruitingThis is an early-stage study to test the safety and find the right dose of a new drug called FZ-AD005 for adults with aggressive brain tumors that have come back or stopped responding to standard treatments. The study will enroll about 40 people with high-grade gliomas, including…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
First patients sought for groundbreaking brain tumor drug trial
Disease control Not yet recruitingThis is the first study in people testing a new drug called MT-125, given alongside standard radiation therapy for a fast-growing type of brain cancer called glioblastoma. The main goal is to find the highest dose that is safe and tolerable for patients. Researchers will enroll u…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: PHASE1 • Sponsor: Myosin Therapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Scientists test supercharged immune cells against deadly brain cancer
Disease control Not yet recruitingThis early-stage study is testing a new type of cell therapy for adults with glioblastoma that has come back after treatment. Doctors will collect a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them back. The main goals are to see …
Matched conditions: GLIOBLASTOMA (GBM)
Phase: EARLY_PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Targeted radiation aims to zap brain tumor, spare healthy tissue
Disease control Not yet recruitingThis study is testing a more focused radiation treatment for adults with glioblastoma, a serious brain cancer, after they have had surgery. The goal is to see if precisely targeting a smaller area around the tumor site is as effective at controlling the cancer as standard radiati…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: NA • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC
-
New hope for fighting deadly brain tumors: experimental drug combo enters testing
Disease control Not yet recruitingThis study is testing whether adding a new oral drug called silevertinib to standard chemotherapy (temozolomide) helps people with a specific type of aggressive brain cancer (glioblastoma) live longer without their cancer getting worse. It will involve about 162 newly diagnosed p…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC
-
New 'Glow' microscope aims to sharpen Surgeons' view of brain tumors
Diagnosis Not yet recruitingThis study is testing a new digital camera accessory for a surgical microscope. It aims to help neurosurgeons see suspected aggressive brain tumors more clearly during surgery. The study will observe 37 patients in Europe to see if the new tool provides better image quality and v…
Matched conditions: GLIOBLASTOMA (GBM)
Sponsor: Leica Microsystems (Schweiz) AG • Aim: Diagnosis
Last updated Mar 27, 2026 12:39 UTC
-
Researchers probe hidden mental toll of deadly brain cancer
Knowledge-focused Not yet recruitingThis study aims to understand the mental health challenges faced by people with glioblastoma, a serious brain cancer. Researchers will ask 176 adult patients in Germany to fill out questionnaires about depression, anxiety, suicidal thoughts, and quality of life. The goal is to id…
Matched conditions: GLIOBLASTOMA (GBM)
Sponsor: University Hospital, Essen • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC